http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5580761-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_856b351c9343386c2ca301894391bc95
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-13022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-15022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16043
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1132
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1131
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
filingDate 1994-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1996-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65b1d77703bf73bc9575a266b83305e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51f51aea4204696b4acd9f23d9978864
publicationDate 1996-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5580761-A
titleOfInvention Method of conferring resistance to immunodeficiency viral infection
abstract In accordance with the present invention, disclosed is a method of conferring, upon a host cell, resistance to retroviral infection by interfering with one or more of the infection processes including retroviral replication and assembly into infective viral particles. The method involves introducing a vector into a host cell, wherein the vector comprises a polynucleotide which directs transcription, within the host cell, of RNA which is a) complementary or corresponding, depending on the target region, to a nucleic acid sequence within one or more regions of the genome of the retrovirus; and b) is effective in inhibiting one or more steps in the retroviral infection process by interfering with retroviral replication, reverse transcription, translation, or assembly into viral particles when the host cell is infected. Also disclosed is a method of treatment using the nucleic acid constructs, or cells upon which resistance to infection has been conferred.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9900490-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7964714-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7332588-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7323557-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6960709-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7615685-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7064248-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9900490-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007105795-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007003572-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7547820-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6271016-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6776986-B1
priorityDate 1988-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8703451-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4806463-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398800
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135797799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127850182
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420718
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128530096
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5361
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1188
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44630569

Total number of triples: 54.